Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 6:50 PM
Ignite Modification Date: 2025-12-25 @ 4:22 PM
NCT ID: NCT01311557
Description: Solicited (non serious) adverse events were recorded in diary cards by the study participants or their guardians within 7 days after vaccination.
Frequency Threshold: 5.00
Time Frame: Adverse event data were collected from Day 0 up to Day 30 post-vaccination
Study: NCT01311557
Study Brief: Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Participants 10 to <11 Years of Age Participants received 1 dose of Adacel® vaccine at Visit 1. None None 0 651 521 651 View
Participants 11 to <12 Years of Age Participants received 1 dose of Adacel® vaccine at Visit 1. None None 1 651 522 651 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Cerebrovascular accident NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 13.0 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Injection-site Pain SYSTEMATIC_ASSESSMENT General disorders MedDRA 13.0 View
Injection-site Erythema SYSTEMATIC_ASSESSMENT General disorders MedDRA 13.0 View
Injection-site Swelling SYSTEMATIC_ASSESSMENT General disorders MedDRA 13.0 View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 13.0 View
Malaise SYSTEMATIC_ASSESSMENT General disorders MedDRA 13.0 View
Myalgia SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 13.0 View